Elymbus 0.1 mg/g eye gel in single-dose container Iirimaa - inglise - HPRA (Health Products Regulatory Authority)

elymbus 0.1 mg/g eye gel in single-dose container

laboratoires thea - bimatoprost - eye gel in single-dose container - bimatoprost

Ganzed 0.3 mg/ml - 5 mg/ml eye drops sol. dropper cont. Belgia - inglise - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

ganzed 0.3 mg/ml - 5 mg/ml eye drops sol. dropper cont.

horus pharma - timolol maleate 6,83 mg/ml - eq. timolol 5 mg/ml; bimatoprost 0,3 mg/ml - eye drops, solution - 0,3 mg/ml - 5 mg/ml - bimatoprost 0.3 mg/ml; timolol maleate 6.83 mg/ml - timolol, combinations

Vizimaco 0.3 mg/ml - 5 mg/ml eye drops sol. multidos. cont. Belgia - inglise - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

vizimaco 0.3 mg/ml - 5 mg/ml eye drops sol. multidos. cont.

bausch + lomb ireland - timolol maleate 6,83 mg/ml - eq. timolol 5 mg/ml; bimatoprost 0,3 mg/ml - eye drops, solution - 0,3 mg/ml + 5 mg/ml - bimatoprost 0.3 mg/ml; timolol maleate 6.83 mg/ml - timolol, combinations

BIMATOPROST S.K. Iisrael - inglise - Ministry of Health

bimatoprost s.k.

k.s.kim international (sk- pharma) ltd., israel - bimatoprost - ophthalmic solution - bimatoprost 0.3 mg / 1 ml - bimatoprost - reduction of elevated intraocular pressure in chronic open angle glaucoma and ocular hypertension (as monotherapy or as adjunctive therapy to beta-blockers).

LUMIGAN 0.1MG/ML EYE DROPS Eye drops, solution Saudi Araabia - inglise - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

lumigan 0.1mg/ml eye drops eye drops, solution

allergan pharmaceuticals ltd, ireland - bimatoprost - eye drops, solution - 0.1 mg/ml

LUMIGAN 0.3MG - ML EYE DROPS Eye drops, solution Saudi Araabia - inglise - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

lumigan 0.3mg - ml eye drops eye drops, solution

allergan pharmaceuticals ltd - bimatoprost - eye drops, solution - 0.3 %

Lumigan 0.01% Eye Drops, Solution Kenya - inglise - Pharmacy and Poisons Board

lumigan 0.01% eye drops, solution

allergan pharmaceuticals (pty) ltd 30 new road, (entrance of bavaria ave) - bimatoprost - eye drops, solution - 1 ml contains 0.1mg - antiglaucoma preparations and miotics

LUMIGAN 0.1MG/ML EYE DROPS Eye drops, solution Saudi Araabia - inglise - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

lumigan 0.1mg/ml eye drops eye drops, solution

abbvie deutschland gmbh, germany - bimatoprost - eye drops, solution - 0.1 mg/ml

ILEVRO nepafenac 0.3% eye drops, suspension, bottle Austraalia - inglise - Department of Health (Therapeutic Goods Administration)

ilevro nepafenac 0.3% eye drops, suspension, bottle

novartis pharmaceuticals australia pty ltd - nepafenac, quantity: 3 mg/ml - eye drops, suspension - excipient ingredients: carbomer 974p; carmellose sodium; benzalkonium chloride; boric acid; sodium hydroxide; hydrochloric acid; sodium chloride; propylene glycol; guar galactomannan; purified water; disodium edetate - ilevro is indicated for the:,- prevention and treatment of postoperative pain and inflammation associated with cataract surgery,- reduction in risk of postoperative macular oedema associated with cataract surgery in patients with non proliferative diabetic retinopathy.

ILEVRO nepafenac 0.3% eye drops, suspension, oval bottle Austraalia - inglise - Department of Health (Therapeutic Goods Administration)

ilevro nepafenac 0.3% eye drops, suspension, oval bottle

novartis pharmaceuticals australia pty ltd - nepafenac, quantity: 3 mg/ml - eye drops, suspension - excipient ingredients: carbomer 974p; carmellose sodium; benzalkonium chloride; boric acid; sodium hydroxide; hydrochloric acid; sodium chloride; propylene glycol; guar galactomannan; purified water; disodium edetate - ilevro is indicated for the:,- prevention and treatment of postoperative pain and inflammation associated with cataract surgery,- reduction in risk of postoperative macular oedema associated with cataract surgery in patients with non proliferative diabetic retinopathy.